The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.

@article{Tellor2014TheUO,
  title={The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.},
  author={Bethany R. Tellor and Jennifer R. Smith and S Maheshwara Prasad and Susan Joseph and Scott C. Silvestry},
  journal={The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  year={2014},
  volume={33 1},
  pages={94-101}
}
BACKGROUND Pump thrombosis in patients with left ventricular assist devices (LVADs) continues to present treatment challenges. Anti-coagulation strategies used to treat this complication are empiric and without firm data for guidance. The addition of a platelet glycoprotein IIb/IIIa inhibitor to intravenous anti-coagulation has been suggested by several case series and recent guidelines. The aim of this study was to evaluate our use of eptifibatide for the treatment of suspected pump thrombus… CONTINUE READING